王凤君;李伟;

• 1:西安医学院
• 2:陕西省人民医院

摘要(Abstract)：

转甲状腺素蛋白(transthyretin,TTR),一种同源四聚体蛋白,因其电泳迁移恰好在白蛋白之前,故命名为前白蛋白(prealbumin,PA)。TTR对大脑的生长、发育功能有着重要作用,很多学者开始研究其与缺血性脑卒中的严重程度及预后、抑郁症、阿尔茨海默病(alzheimer’s disease,AD)及淀粉样变性病的相关性。本文就TTR在中枢神经系统疾病的临床意义及研究进展作一综述。

关键词(KeyWords)： 转甲状腺素蛋白;中枢神经系统;缺血性脑卒中;抑郁症;阿尔茨海默病;淀粉样变性病

Abstract:

Keywords:

基金项目(Foundation): 陕西省科学技术研究发展计划项目(编号:S2015YFSF0325)

作者(Authors): 王凤君;李伟;

参考文献(References)：

• [1] VIEIRA M,SARAIVA M J.Transthyretin:a multifaceted protein[J].Biomol Concepts,2014,5(1):45-54.DOI:10.1515/bmc-2013-0038.
• [2] BLAKE C C,GEISOW MJ,SWAN I D,et al.Strjcture of human plasma prealbumin at 2-5 A resolution.A preliminary report on the polypeptide chain conformation,quaternary structure and thyroxine binding[J].J Mol Biol,1974,88(1):1-12.DOI:10.1016/0022-2836(74)90291-5.
• [3] WOJTCZAK A,CODY V,LUFT J R,et al.Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution:first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sites[J].Acta Crystallogr D Biol Crystallogr,2001,57(Pt 8):1061-1070.DOI:10.1107/s0907444901007235.
• [4] BLAKE C C,GEISOW M J,OATLEY S J,et al.Structure of prealbumin:secondary,tertiary and quaternary interactions determined by Fourier refinement at 1.8 A[J].J Mol Biol,1978,121(3):339-356.DOI:10.1016/0022-2836(78)90368-6.
• [5] HAMILTON J A,STEINRAUF L K,BRADEN B C,et al.The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution[J].J Biol Chem,1993,268(4):2416-2424.
• [6] CARVALHO A,ROCHA A,LOBATO L.Liver transplantation in transthyretin amyloidosis:issues and challenges[J].Liver Transpl,2015,21(3):282-292.DOI:10.1002/lt.24058.
• [7] KEEP R F,JONES H C,DREWES L R.This was the year that was:brain barriers and brain fluid research in 2019[J].Fluids Barriers CNS,2020,17(1):20.DOI:10.1186/s12987-020-00181-9.
• [8] SKLAN D,ROSS A C.Synthesis of retinol-binding protein and transthyretin in yolk sac and fetus in the rat[J].J Nutr,1987,117(3):436-442.DOI:10.1093/jn/117.3.436.
• [9] RICHARDSON S J.Evolutionary changes to transthyretin:evolution oftransthyretin biosynthesis[J].FEBS J,2009,276(19):5342-5356.DOI:10.1111/j.1742-4658.2009.07244.x.
• [10] POWER D M,ELIAS N P,RICHARDSON S J,et al.Evolution of the thyroid hormone-binding protein,transthyretin[J].Gen Comp Endocrinol,2000,119(3):241-255.DOI:10.1006/gcen.2000.7520.
• [11] RICHARDSON S J.Cell and molecular biology of transthyretin and thyroid hormones[J].Int Rev Cytol,2007,258:137-193.DOI:10.1016/S0074-7696(07)58003-4.
• [12] OLIVEIRA S M,CARDOSO I,SARAIVA M J.Transthyretin:roles in the nervous system beyond thyroxine and retinol transport[J].Expert Rev Endocrinol Metab,2012,7(2):181-189.DOI:10.1586/eem.12.2.
• [13] RICHARDSON S J,WIJAYAGUNARATNE R C,D'SOUZA D G,et al.Transport of thyroid hormones via the choroid plexus into the brain:the roles of transthyretin and thyroid hormone transmembrane transporters[J].Front Neurosci,2015,9:66.DOI:10.3389/fnins.2015.00066.
• [14] VIEIRA M,SARAIVA M J.Transthyretin regulates hippocampal 14-3-3ζ protein levels[J].FEBS Lett,2013,587(10):1482-1488.DOI:10.1016/j.febslet.2013.03.011.
• [15] DELPONT B,ABOA-EBOULE′ C,DURIER J,et al.Associations between Thyroid Stimulating Hormone Levels and Both Severity and Early Outcome of Patients with Ischemic Stroke[J].Eur Neurol,2016,76:125-131.DOI:10.1159/000449055.
• [16] WANG Y,QIN W,HU W.An analysis of the risk of perioperative ischemic stroke in patients undergoing non-cardiovascular and non-neurological surgeries[J].Neurol Res,2020,42(1):55-61.DOI:10.1080/01616412.2019.1709140.
• [17] MAO H,WU Q,LIN P,et al.Derivation of a Prediction Rule for Unfavorable Outcome after Ischemic Stroke in the Chinese Population[J].J Stroke Cerebrovasc Dis,2019,28(1):133-141.DOI:10.1016/j.jstrokecerebrovasdis.2018.09.025.
• [18] GAO C,ZHANG B,ZHANG W,et al.Serum prealbumin (transthyretin) predict good outcome in young patients with cerebral infarction[J].Clin Exp Med,2011,11(1):49-54.DOI:10.1007/s10238-010-0103-8.
• [19] YE S,LIN SP,WU K,et al.Serum prealbumin is a predictive biomarker for stroke-associated infection after an ischemic stroke[J].Int J Neurosci,2017,127(7):601-605.DOI:10.1080/00207454.2016.1218874.
• [20] AMBROSIUS W,MICHALAK S,KAZMIERSKI R,et al.Predictive value of serum transthyretin for outcome in acute ischemic stroke[J].PLoS One,2017,12(6):e0179806.DOI:10.1371/journal.pone.0179806.
• [21] ZHANG H,SHU Y,ZHANG J,et al.Dynamics of nutritional status in dying patients with acute cerebral infarction in central China:a preliminary study[J].Neurol Res,2011,33(5):503-507.DOI:10.1179/016164111X13007856084160.
• [22] CRARY M A,HUMPHREY J L,CARNABY-MANN G,et al.Dysphagia,nutrition,and hydration in ischemic stroke patients at admission and discharge from acute care[J].Dysphagia,2013,28(1):69-76.DOI:10.1007/s00455-012-9414-0.
• [23] PELLICANE A J,MILLIS S R,BARKER K D,et al.The effect of protein and calorie intake on prealbumin,complications,length of stay,and function in the acute rehabilitation inpatient with stroke[J].NeuroRehabilitation,2013,33(3):367-376.DOI:10.3233/NRE-130966.
• [24] BERNAL J,GUADA?O-FERRAZ A,MORTE B.Perspectives in the study of thyroid hormone action on brain development and function[J].Thyroid,2003,13(11):1005-1012.DOI:10.1089/105072503770867174.
• [25] MORREALE DE ESCOBAR G,OBREGON M J,ESCOBAR DEL REY F.Maternal thyroid hormones early in pregnancy and fetal brain development[J].Best Pract Res Clin Endocrinol Metab,2004,18(2):225-248.DOI:10.1016/j.beem.2004.03.012.
• [26] HAGGERTY J J J R,PRANGE A J J R.Borderline hypothyroidism and depression[J].Annu Rev Med,1995,46:37-46.DOI:10.1176/ajp.150.5.813.
• [27] HATTERER J A,HERBERT J,HIDAKA C,et al.CSF transthyretin in patients with depression[J].Am J Psychiatry,1993,150(5):813-815.DOI:10.1176/ajp.150.5.813.
• [28] SULLIVAN G M,HATTERER J A.Low levels of transthyretin in the CSF of depressed patients[J].Am J Psychiatry,1999,156(5):710-715.DOI:10.1176/ajp.156.5.710.
• [29] WANG L,XU H,REN W,et al.Low serum prealbumin levels in post-stroke depression[J].Psychiatry Res,2016,246:149-153.DOI:10.1016/j.psychres.2016.09.021.
• [30] SULLIVAN G M,MANN J J,OQUENDO M A,et al.Low cerebrospinal fluid transthyretin levels in depression:correlations with suicidal ideation and low serotonin function[J].Biol Psychiatry,2006,60(5):500-506.DOI:10.1016/j.biopsych.2005.11.022.
• [31] FRYE M A,NASSAN M,JENKINS G D,et al.Feasibility of investigating differential proteomic expression in depression:implications for biomarker development in mood disorders[J].Transl Psychiatry,2015,5(12):e689.DOI:10.1038/tp.2015.185.
• [32] SCHULTZ K,TR?SKMAN-BENDZ L,PETERSéN A.Transthyretin in cerebrospinal fluid from suicide attempters[J].J Affect Disord,2008,109(1-2):205-208.DOI:10.1016/j.jad.2007.11.007.
• [33] FRYE M A,NASSAN M,JENKINS G D,et al.Feasibility of investigating differential proteomic expression in depression:implications for biomarker development in mood disorders [J].Transl Psychiatry,2015,5(12):e689.DOI:10.1038/tp.2015.185.
• [34] SCHULTZ K,TR?SKMAN-BENDZ L,PETERSéN A.Transthyretin in cerebrospinal fluid from suicide attempters [J].J Affect Disord,2008,109(1-2):205-208.DOI:10.1016/j.jad.2007.11.007.
• [35] ELOVAARA I,MAURY C P,PALO J.Serum amyloid A protein,albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome[J].Acta Neurol Scand,1986,74(3):245-250.
• [36] SCHWARZMAN A L,GREGORI L,VITEK M P,et al.Transthyretin sequesters amyloid beta protein and prevents amyloid formation[J].Proc Natl Acad,1994,91:8368-8372.DOI:10.1073/pnas.91.18.8368.
• [37] SEROT J M,CHRISTMANN D,DUBOST T,et al.Cerebrospinal fluid transthyretin:aging and late onset Alzheimer's disease[J].J Neurol Neurosurg Psychiatry,1997,63(4):506-508.DOI:10.1136/jnnp.63.4.506.
• [38] SEROT J M,BéNé M C,FOLIGUET B,et al.Morphological alterations of the choroid plexus in late-onset Alzheimer's disease[J].Acta Neuropathol,2000,99(2):105-108.DOI:10.1007/pl00007412.
• [39] RIIS?EN H.Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease[J].Acta Neurol Scand,1988,78(6):455-459.DOI:10.1111/j.1600-0404.1988.tb03687.x.
• [40] CASTA?O E M,ROHER A E,ESH C L,et al.Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects[J].Neurol Res,2006,28(2):155-163.DOI:10.1179/016164106X98035.
• [41] SCHULTZ K,NILSSON K,NIELSEN J E,et al.Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies:effects of treatment with cholinesterase inhibitors[J].Eur J Neurol,2010,17(3):456-460.DOI:10.1111/j.1468-1331.2009.02841.x.
• [42] TIEN Y T,LEE W J,LIAO Y C,et al.Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia[J].Sci Rep,2019,9(1):18691.DOI:10.1038/s41598-019-55318-0.
• [43] VELAYUDHAN L,KILLICK R,HYE A,et al.Plasma transthyretin as a candidate marker for Alzheimer's disease[J].J Alzheimers Dis,2012,28(2):369-375.DOI:10.3233/JAD-2011-110611.
• [44] RIOS X,GOMEZ-VALLEJO V,MARTIN A,et al.Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal,a TTR tetramer stabilizer and a new candidate drug for AD[J].Sci Rep,2019,9(1):13672.Published 2019 Sep 20.DOI:10.1038/s41598-019-50071-w.
• [45] BUXBAUM J N.Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy[J].Degener Neurol Neuromuscul Dis,2012,2:165-173.DOI:10.2147/DNND.S24624.
• [46] RUBERG F L,BERK J L.Transthyretin (TTR) cardiac amyloidosis[J].Circulation,2012,126(10):1286-1300.DOI:10.1161/CIRCULATIONAHA.111.078915
• [47] CONNORS L H,LIM A,PROKAEVA T,et al.Tabulation of human transthyretin (TTR) variants,2003[J].Amyloid,2003,10(3):160-184.DOI:10.3109/13506120308998998.
• [48] TSUZUKI T,MITA S,MAEDA S,et al.Structure of the humanprealbumin gene[J].J Biol Chem,1985,260:12224-12227.
• [49] ADAMS D,CAUQUIL C,LABEYRIE C,et al.TTR kinetic stabilizers and TTR gene silencing:a new era in therapy for familial amyloidotic polyneuropathies[J].Expert Opin Pharmacother,2016,17(6):791-802.DOI:10.1517/14656566.2016.1145664.
• [50] LOPES A,FONSECA I,SOUSA A,et al.Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy[J].Biomed Hub,2017,2(3):1-14.DOI:10.1159/000485118.
• [51] MANSO M C,MARQUES D P,ROCHA S L,et al.Senile Systemic Amyloidosis:An Underdiagnosed Disease[J].Eur J Case Rep Intern Med,2017,4(9):000725.DOI:10.12890/2017_000725.
• [52] SEKIJIMA Y.Recent progress in the understanding and treatment of transthyretin amyloidosis[J].J Clin Pharm Ther,2014,39(3):225-233.DOI:10.1111/jcpt.12145.
• [53] WESTERMARK P,WESTERMARK GT,SUHR OB,et al.Transthyretin-derived amyloidosis:probably a common cause of lumbar spinal stenosis[J].Ups J Med Sci,2014,119(3):223-228.DOI:10.3109/03009734.2014.895786.
• [54] ADAMS D,GONZALEZ-DUARTE A,O'RIORDAN WD,et al.Patisiran,an RNAi Therapeutic,for Hereditary Transthyretin Amyloidosis[J].The New England journal of medicine,2018,379(1):11-21.DOI:10.1056/NEJMoa1716153.
• [55] KRISTEN A V,AJROUD-DRISS S,CONCEI??O I,et al.Patisiran,an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis[J].Neurodegener Dis Manag,2019,9(1):5-23.DOI:10.2217/nmt-2018-0033.
• [56] KOIKE H,KATSUN M.Ultrastructure in TransthyretinO Amyloidosis:From Pathophysiology to Therapeutic Insights[J].Biomedicines,2019,7(1):11.DOI:10.3390/biomedicines7010011